Photogen initiates development of ocular disease Rx; receives U.S. patents for technology Dec. 7, 1998 No Comments
Olopatadine combination more effective than loratadine monotherapy in allergic conjunctivitis Nov. 27, 1998 No Comments
CytoTherapeutics receives patent protection for ocular delivery of therapeutic substances Nov. 25, 1998 No Comments
First marketing approval granted for Vitrase in Mexico; U.S. phase III trials now under way Nov. 24, 1998 No Comments
Latanoprost monotherapy is as effective as combination therapy in lowering IOP Nov. 20, 1998 No Comments
New prostaglandins with IOP-lowering effects disclosed by Santen and Asahi Glass Nov. 16, 1998 No Comments